---
figid: PMC6590809__pone.0218459.g001
figtitle: Apical sodium-dependent bile acid transporter inhibition with volixibat
  improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden
  mice
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Mus musculus
- Homo sapiens
pmcid: PMC6590809
filename: pone.0218459.g001.jpg
figlink: /pmc/articles/PMC6590809/figure/pone.0218459.g001/
number: F1
caption: 'Primary bile acids are synthesized from cholesterol in the liver, via either
  the classical pathway, which produces CA, or the alternative pathway, which produces
  CDCA, or, in mice only, α- or β-MCA.[, ] Bile acids are conjugated with glycine
  or taurine (predominantly taurine in mice) before being released into the bile.[]
  In the gut, bile acids are deconjugated and metabolized into secondary bile acids
  [, , ] (UDCA is considered a secondary bile acid in humans [] but a primary bile
  acid in mice).[] About 95% of bile acids are reabsorbed from the gut and transported
  back to the liver via the hepatic portal vein, and the remainder are excreted.[,
  , ] The hydrophilicity of the common free and conjugated bile salts decreases in
  the order UDCA > CA > CDCA > DCA) > LCA, and taurine-conjugated > glycine-conjugated
  > free species.[] ASBT inhibition with volixibat blocks the reabsorption of bile
  acids and increases their excretion, stimulating the liver to synthesize more bile
  acids from cholesterol.[–] ASBT: apical sodium-dependent bile acid transporter,
  CA: cholic acid, CDCA: chenodeoxycholic acid, Cyp: cytochrome P450 family, DCA:
  deoxycholic acid, G: glycine, HDCA: hyodeoxycholic acid, LCA: lithocholic acid,
  MCA: muricholic acid, T: taurine, UDCA: ursodeoxycholic acid.'
papertitle: Apical sodium-dependent bile acid transporter inhibition with volixibat
  improves metabolic aspects and components of non-alcoholic steatohepatitis in Ldlr-/-.Leiden
  mice.
reftext: Kanita Salic, et al. PLoS One. 2019;14(6):e0218459.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.7350302
figid_alias: PMC6590809__F1
figtype: Figure
redirect_from: /figures/PMC6590809__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6590809__pone.0218459.g001.html
  '@type': Dataset
  description: 'Primary bile acids are synthesized from cholesterol in the liver,
    via either the classical pathway, which produces CA, or the alternative pathway,
    which produces CDCA, or, in mice only, α- or β-MCA.[, ] Bile acids are conjugated
    with glycine or taurine (predominantly taurine in mice) before being released
    into the bile.[] In the gut, bile acids are deconjugated and metabolized into
    secondary bile acids [, , ] (UDCA is considered a secondary bile acid in humans
    [] but a primary bile acid in mice).[] About 95% of bile acids are reabsorbed
    from the gut and transported back to the liver via the hepatic portal vein, and
    the remainder are excreted.[, , ] The hydrophilicity of the common free and conjugated
    bile salts decreases in the order UDCA > CA > CDCA > DCA) > LCA, and taurine-conjugated
    > glycine-conjugated > free species.[] ASBT inhibition with volixibat blocks the
    reabsorption of bile acids and increases their excretion, stimulating the liver
    to synthesize more bile acids from cholesterol.[–] ASBT: apical sodium-dependent
    bile acid transporter, CA: cholic acid, CDCA: chenodeoxycholic acid, Cyp: cytochrome
    P450 family, DCA: deoxycholic acid, G: glycine, HDCA: hyodeoxycholic acid, LCA:
    lithocholic acid, MCA: muricholic acid, T: taurine, UDCA: ursodeoxycholic acid.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Cyp27a1
  - Cyp7b1
  - Bmca
  - Gnat2
  - Gusb
  - Slc10a2
  - Clta
  - Ptprc
  - Hdc
  - Cyp7a1
  - Cyp8b1
  - CYP27A1
  - CYP7B1
  - SLC10A2
  - HLA-DQA2
  - CLTA
  - GUCY2D
  - PTPRC
  - CYP7A1
  - CYP8B1
  - Cholesterol
  - Ta
  - hydroxycholesterol
  - bile acids
  - CDCA
  - B-MCA
  - UDCA
  - T-CDCA
  - DCA
  - HDCA
---
